High-dose-rate versus low-dose-rate monotherapy in the treatment of localized prostate cancer: The case for low-dose-rate monotherapy.

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish
Pages (from-to)5-6; discussion 8
JournalBrachytherapy
Volume5
Issue number1
DOIs
StatePublished - 2006

Cite this